Published

ID: 212703 Augmenting rTMS With Psilocybin-Assisted Psychotherapy (PAP) for PTSD: A Proof-of-Concept Study Design

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Neuromodulation Technology at the Neural Interface
Date: 2023-06-01
Source: OpenAlex
DOI: 10.1016/j.neurom.2023.04.144
PubMed: Unavailable

Authors

Basant Pradhan Ankit Rana Edward Goldschmidt Anthony L. Rostain

Watch author

Derived topics and classifications

psilocybin PTSD Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

ID: 212703 Augmenting rTMS With Psilocybin-Assisted Psychotherapy (PAP) for PTSD: A Proof-of-Concept Study Design2023-06-01

Related papers

S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-19 An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic TherapyClinicalTrials.gov · 2026-08-06 Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted PsychotherapyClinicalTrials.gov · 2026-04-22 PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related BurnoutClinicalTrials.gov · 2024-11-12